지속성 약물전달 기술 및 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 기술별, 제형별, 사용 재료별, 유통경로별, 지역별, 경쟁별 세분화(2020-2030년)
Long-Acting Drug Delivery Technologies and Services Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique, By Dosage Forms, By Material Used, By Distribution Channels, By Region and Competition, 2020-2030F
상품코드:1886297
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 지속성 약물전달 기술 및 서비스 시장은 2024년에 107억 8,000만 달러로 평가되며, 2030년까지 CAGR 11.10%로 성장하며, 202억 7,000만 달러에 달할 것으로 예측됩니다. 지속형 약물전달 기술 및 서비스에는 장기간에 걸쳐 치료제를 방출하도록 설계된 시스템이 포함되어 있으며, 투여 빈도를 줄이고 환자의 복약 순응도를 향상시킵니다. 시장 확대를 지원하는 주요 요인으로는 최적의 관리를 위해 지속적인 투약이 필요한 만성질환의 유병률 증가, 특히 주사제 및 이식형 제제의 환자 편의성 향상에 대한 수요 증가를 꼽을 수 있습니다. 약물 농도를 일정하게 유지하여 피크 트러프 효과를 최소화하는 고유한 장점도 이러한 혁신적인 약물전달 솔루션의 근본적인 촉진제 역할을 합니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
107억 8,000만 달러
시장 규모 : 2030년
202억 7,000만 달러
CAGR : 2025-2030년
11.10%
가장 빠르게 성장하는 부문
주사제
최대 시장
북미
주요 시장 성장 촉진요인
세계에서 만성질환에 대한 부담이 증가함에 따라 장기간에 걸쳐 지속적인 치료 관리가 필요한 만성질환의 경우, 지속형 약물전달 기술 및 서비스에 대한 수요가 크게 증가하고 있습니다. 당뇨병, 심혈관질환, 각종 신경질환 등의 질환은 합병증을 예방하고 환자의 예후를 개선하기 위해 일관된 약물 농도를 유지해야 합니다.
주요 시장 과제
신규 장기지속형 제제 연구개발(R&D)에 대한 막대한 자금 투자는 세계 장기지속형 약물전달 기술 및 서비스 시장의 성장에 큰 걸림돌이 되고 있습니다. 이 문제는 혁신적인 제품이 시장에 진입하기까지 많은 자본이 필요하고 장기간의 시간이 소요되는 문제를 직접적으로 야기합니다.
주요 시장 동향
치료용 분자의 복잡성이 증가함에 따라 생물제제 기반의 장기지속형 제제에 대한 관심이 높아지고 있는 것은 약물전달 시장의 중요한 동향입니다. 이러한 제제는 생물제제의 반감기를 연장하고 주사 빈도를 감소시킵니다. 이는 특히 만성질환에서 환자의 편안함과 복약 순응도에 매우 중요합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 지속성 약물전달 기술 및 서비스 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
기술별(주사제, 하이드로겔, 임플란트, 마이크로니들, 나노 결정 현탁액)
제형별(지속성 주사제, 지속성 이식제, 외용/경피제, 질제, 기타)
사용 재료별(폴리머계, 비폴리머계)
유통경로별(병원·소매 약국, 조사기관·학술기관, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 지속성 약물전달 기술 및 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 지속성 약물전달 기술 및 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 지속성 약물전달 기술 및 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 지속성 약물전달 기술 및 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 지속성 약물전달 기술 및 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 지속성 약물전달 기술 및 서비스 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Adare Pharma Solutions
Alkermes plc
Camurus AB
Corium, LLC.
Creative Biolabs, Inc.
Delpor, Inc.
Durect Corporation
Hanmi Pharm.Co.,Ltd.
Integrated Bio Systems, Inc.
Heron Therapeutics, Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Long-Acting Drug Delivery Technologies and Services Market, valued at USD 10.78 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 20.27 Billion by 2030. Long-acting drug delivery technologies and services encompass systems designed to release therapeutic agents over extended periods, reducing dosing frequency and improving patient adherence. Primary drivers supporting market expansion include the increasing prevalence of chronic diseases necessitating sustained medication for optimal management and the growing demand for enhanced patient convenience, especially for injectable or implantable formulations. The inherent benefit of maintaining consistent drug levels, thereby minimizing peak-and-trough effects, also represents a fundamental driver for these innovative delivery solutions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 10.78 Billion
Market Size 2030
USD 20.27 Billion
CAGR 2025-2030
11.10%
Fastest Growing Segment
Injectables
Largest Market
North America
Key Market Drivers
The rising global burden of chronic diseases significantly influences the demand for long-acting drug delivery technologies and services, as these conditions necessitate sustained therapeutic management over extended periods. Diseases such as diabetes, cardiovascular disease, and various neurological disorders require consistent medication levels to prevent complications and improve patient outcomes.
Key Market Challenges
The significant financial investment associated with research and development (R&D) for novel long-acting formulations presents a notable impediment to the growth of the Global Long-Acting Drug Delivery Technologies and Services Market. This challenge directly results in substantial capital requirements and prolonged timelines before innovative products can achieve market entry. The complexity of developing formulations that ensure sustained release and stability over extended periods necessitates extensive preclinical and clinical testing, further escalating costs and extending development cycles.
Key Market Trends
The growing emphasis on biologic-based long-acting formulations represents a significant trend in the drug delivery market, driven by the increasing complexity of therapeutic molecules. These formulations extend the half-life of biologics, thereby reducing the frequency of injections which is crucial for patient comfort and adherence, especially for chronic conditions. Biologics, including monoclonal antibodies and protein-based therapies, often require complex manufacturing and administration regimens, making long-acting versions highly advantageous.
Key Market Players
Adare Pharma Solutions
Alkermes plc
Camurus AB
Corium, LLC.
Creative Biolabs, Inc.
Delpor, Inc.
Durect Corporation
Hanmi Pharm.Co.,Ltd.
Integrated Bio Systems, Inc.
Heron Therapeutics, Inc.
Report Scope:
In this report, the Global Long-Acting Drug Delivery Technologies and Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Long-Acting Drug Delivery Technologies and Services Market, By Technique:
Injectables
Hydrogels
Implants
Microneedles
NanocrystalSuspensions
Long-Acting Drug Delivery Technologies and Services Market, By Dosage Forms:
Long-acting Injectables
Long-acting Implantable
Topical / Transdermal
Vaginal
Other
Long-Acting Drug Delivery Technologies and Services Market, By Material Used:
Polymer based
Non-polymer based
Long-Acting Drug Delivery Technologies and Services Market, By Distribution Channels:
Hospitals and Retail Pharmacies
Research and Academics
Others
Long-Acting Drug Delivery Technologies and Services Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Long-Acting Drug Delivery Technologies and Services Market.
Available Customizations:
Global Long-Acting Drug Delivery Technologies and Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Long-Acting Drug Delivery Technologies and Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (Injectables, Hydrogels, Implants, Microneedles, NanocrystalSuspensions)
5.2.2. By Dosage Forms (Long-acting Injectables, Long-acting Implantable, Topical / Transdermal, Vaginal, Other)
5.2.3. By Material Used (Polymer based, Non-polymer based)
5.2.4. By Distribution Channels (Hospitals and Retail Pharmacies, Research and Academics, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Long-Acting Drug Delivery Technologies and Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique
6.2.2. By Dosage Forms
6.2.3. By Material Used
6.2.4. By Distribution Channels
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Long-Acting Drug Delivery Technologies and Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technique
6.3.1.2.2. By Dosage Forms
6.3.1.2.3. By Material Used
6.3.1.2.4. By Distribution Channels
6.3.2. Canada Long-Acting Drug Delivery Technologies and Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technique
6.3.2.2.2. By Dosage Forms
6.3.2.2.3. By Material Used
6.3.2.2.4. By Distribution Channels
6.3.3. Mexico Long-Acting Drug Delivery Technologies and Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technique
6.3.3.2.2. By Dosage Forms
6.3.3.2.3. By Material Used
6.3.3.2.4. By Distribution Channels
7. Europe Long-Acting Drug Delivery Technologies and Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Dosage Forms
7.2.3. By Material Used
7.2.4. By Distribution Channels
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Long-Acting Drug Delivery Technologies and Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technique
7.3.1.2.2. By Dosage Forms
7.3.1.2.3. By Material Used
7.3.1.2.4. By Distribution Channels
7.3.2. France Long-Acting Drug Delivery Technologies and Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technique
7.3.2.2.2. By Dosage Forms
7.3.2.2.3. By Material Used
7.3.2.2.4. By Distribution Channels
7.3.3. United Kingdom Long-Acting Drug Delivery Technologies and Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technique
7.3.3.2.2. By Dosage Forms
7.3.3.2.3. By Material Used
7.3.3.2.4. By Distribution Channels
7.3.4. Italy Long-Acting Drug Delivery Technologies and Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technique
7.3.4.2.2. By Dosage Forms
7.3.4.2.3. By Material Used
7.3.4.2.4. By Distribution Channels
7.3.5. Spain Long-Acting Drug Delivery Technologies and Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technique
7.3.5.2.2. By Dosage Forms
7.3.5.2.3. By Material Used
7.3.5.2.4. By Distribution Channels
8. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Dosage Forms
8.2.3. By Material Used
8.2.4. By Distribution Channels
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Long-Acting Drug Delivery Technologies and Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technique
8.3.1.2.2. By Dosage Forms
8.3.1.2.3. By Material Used
8.3.1.2.4. By Distribution Channels
8.3.2. India Long-Acting Drug Delivery Technologies and Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technique
8.3.2.2.2. By Dosage Forms
8.3.2.2.3. By Material Used
8.3.2.2.4. By Distribution Channels
8.3.3. Japan Long-Acting Drug Delivery Technologies and Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technique
8.3.3.2.2. By Dosage Forms
8.3.3.2.3. By Material Used
8.3.3.2.4. By Distribution Channels
8.3.4. South Korea Long-Acting Drug Delivery Technologies and Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technique
8.3.4.2.2. By Dosage Forms
8.3.4.2.3. By Material Used
8.3.4.2.4. By Distribution Channels
8.3.5. Australia Long-Acting Drug Delivery Technologies and Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technique
8.3.5.2.2. By Dosage Forms
8.3.5.2.3. By Material Used
8.3.5.2.4. By Distribution Channels
9. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Dosage Forms
9.2.3. By Material Used
9.2.4. By Distribution Channels
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Long-Acting Drug Delivery Technologies and Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technique
9.3.1.2.2. By Dosage Forms
9.3.1.2.3. By Material Used
9.3.1.2.4. By Distribution Channels
9.3.2. UAE Long-Acting Drug Delivery Technologies and Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technique
9.3.2.2.2. By Dosage Forms
9.3.2.2.3. By Material Used
9.3.2.2.4. By Distribution Channels
9.3.3. South Africa Long-Acting Drug Delivery Technologies and Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technique
9.3.3.2.2. By Dosage Forms
9.3.3.2.3. By Material Used
9.3.3.2.4. By Distribution Channels
10. South America Long-Acting Drug Delivery Technologies and Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technique
10.2.2. By Dosage Forms
10.2.3. By Material Used
10.2.4. By Distribution Channels
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Long-Acting Drug Delivery Technologies and Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technique
10.3.1.2.2. By Dosage Forms
10.3.1.2.3. By Material Used
10.3.1.2.4. By Distribution Channels
10.3.2. Colombia Long-Acting Drug Delivery Technologies and Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technique
10.3.2.2.2. By Dosage Forms
10.3.2.2.3. By Material Used
10.3.2.2.4. By Distribution Channels
10.3.3. Argentina Long-Acting Drug Delivery Technologies and Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technique
10.3.3.2.2. By Dosage Forms
10.3.3.2.3. By Material Used
10.3.3.2.4. By Distribution Channels
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Long-Acting Drug Delivery Technologies and Services Market: SWOT Analysis
